Barriers to implementation of dietary therapy for pediatric epilepsy in resource limited countries: Ethiopian experience

There are dramatic worldwide disparities in access to effective epilepsy treatments. Availability of antiseizure medications (ASMs), dietary therapies, surgical, and neurostimulation options is limited in low and middle income countries (LMICs), reducing opportunities to achieve seizure freedom. Ketogenic diet (KD) therapy can result in at least a 50% reduction in seizures in about half of children with drug-resistant epilepsy [1]. The International League Against Epilepsy (ILAE) emphasize the importance of expanding this treatment globally [2].
Source: Pediatric Neurology - Category: Neurology Authors: Tags: Opinion Paper Source Type: research